RYHIX vs. FBTAX
Compare and contrast key facts about Rydex Health Care Fund (RYHIX) and Fidelity Advisor Biotechnology Fund Class A (FBTAX).
RYHIX is managed by Rydex Funds. It was launched on Apr 16, 1998. FBTAX is managed by Fidelity. It was launched on Dec 27, 2000.
Performance
RYHIX vs. FBTAX - Performance Comparison
Loading graphics...
RYHIX vs. FBTAX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
RYHIX Rydex Health Care Fund | -7.45% | 14.42% | 0.61% | 5.84% | -11.59% | 19.27% | 18.84% | 22.77% | 1.56% | 23.48% |
FBTAX Fidelity Advisor Biotechnology Fund Class A | -2.70% | 39.54% | 5.37% | 10.70% | -7.95% | -3.10% | 32.17% | 25.74% | -3.86% | 25.80% |
Returns By Period
In the year-to-date period, RYHIX achieves a -7.45% return, which is significantly lower than FBTAX's -2.70% return. Over the past 10 years, RYHIX has underperformed FBTAX with an annualized return of 7.98%, while FBTAX has yielded a comparatively higher 11.31% annualized return.
RYHIX
- 1D
- 0.41%
- 1M
- -9.41%
- YTD
- -7.45%
- 6M
- 1.01%
- 1Y
- 3.49%
- 3Y*
- 4.22%
- 5Y*
- 3.06%
- 10Y*
- 7.98%
FBTAX
- 1D
- -0.76%
- 1M
- -6.06%
- YTD
- -2.70%
- 6M
- 11.41%
- 1Y
- 42.70%
- 3Y*
- 18.47%
- 5Y*
- 7.93%
- 10Y*
- 11.31%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
RYHIX vs. FBTAX - Expense Ratio Comparison
RYHIX has a 1.35% expense ratio, which is higher than FBTAX's 1.00% expense ratio.
Return for Risk
RYHIX vs. FBTAX — Risk / Return Rank
RYHIX
FBTAX
RYHIX vs. FBTAX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Rydex Health Care Fund (RYHIX) and Fidelity Advisor Biotechnology Fund Class A (FBTAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RYHIX | FBTAX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.22 | 1.56 | -1.35 |
Sortino ratioReturn per unit of downside risk | 0.43 | 2.10 | -1.68 |
Omega ratioGain probability vs. loss probability | 1.05 | 1.27 | -0.21 |
Calmar ratioReturn relative to maximum drawdown | 0.27 | 2.38 | -2.11 |
Martin ratioReturn relative to average drawdown | 0.81 | 9.61 | -8.80 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| RYHIX | FBTAX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.22 | 1.56 | -1.35 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.20 | 0.34 | -0.15 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.45 | 0.46 | -0.01 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.38 | 0.30 | +0.08 |
Correlation
The correlation between RYHIX and FBTAX is 0.81, which is considered to be high. That indicates a strong positive relationship between their price movements. Having highly-correlated positions in a portfolio may signal a lack of diversification, potentially leading to increased risk during market downturns.
Dividends
RYHIX vs. FBTAX - Dividend Comparison
RYHIX's dividend yield for the trailing twelve months is around 2.35%, more than FBTAX's 1.49% yield.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RYHIX Rydex Health Care Fund | 2.35% | 2.18% | 0.00% | 0.00% | 1.64% | 3.19% | 8.81% | 0.00% | 1.76% | 9.17% | 13.88% | 6.39% |
FBTAX Fidelity Advisor Biotechnology Fund Class A | 1.49% | 1.45% | 6.00% | 1.15% | 0.00% | 20.12% | 8.37% | 6.77% | 2.50% | 0.00% | 0.00% | 5.36% |
Drawdowns
RYHIX vs. FBTAX - Drawdown Comparison
The maximum RYHIX drawdown since its inception was -41.27%, smaller than the maximum FBTAX drawdown of -63.55%. Use the drawdown chart below to compare losses from any high point for RYHIX and FBTAX.
Loading graphics...
Drawdown Indicators
| RYHIX | FBTAX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -41.27% | -63.55% | +22.28% |
Max Drawdown (1Y)Largest decline over 1 year | -11.31% | -13.60% | +2.29% |
Max Drawdown (5Y)Largest decline over 5 years | -22.83% | -36.51% | +13.68% |
Max Drawdown (10Y)Largest decline over 10 years | -29.03% | -38.82% | +9.79% |
Current DrawdownCurrent decline from peak | -10.94% | -7.25% | -3.69% |
Average DrawdownAverage peak-to-trough decline | -8.67% | -21.34% | +12.67% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.78% | 4.11% | -0.33% |
Volatility
RYHIX vs. FBTAX - Volatility Comparison
The current volatility for Rydex Health Care Fund (RYHIX) is 4.92%, while Fidelity Advisor Biotechnology Fund Class A (FBTAX) has a volatility of 7.76%. This indicates that RYHIX experiences smaller price fluctuations and is considered to be less risky than FBTAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| RYHIX | FBTAX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.92% | 7.76% | -2.84% |
Volatility (6M)Calculated over the trailing 6-month period | 10.10% | 16.36% | -6.26% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.87% | 25.58% | -7.71% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.67% | 23.24% | -7.57% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 17.64% | 24.55% | -6.91% |